MarkZimmermanMD
Psychiatry • Cranston, RIProfessor, Psychiatry and Human Behavior, Brown University Program in Medicine
Dr. Zimmerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1170 Pontiac Ave
Cranston, RI 02920Phone+1 401-500-0424Fax+1 855-268-5333
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalResidency, Psychiatry, 1990 - 1994
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1990
Certifications & Licensure
RI State Medical License 1994 - 2026
PA State Medical License 1992 - 1994- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 93 citationsA clinically useful depression outcome scale.Mark Zimmerman, Iwona Chelminski, Joseph B. McGlinchey, Michael A. Posternak
Comprehensive Psychiatry. 2008-03-01 - 14 citationsMeasurement-based treatment of residual symptoms using clinically useful depression outcome scale: Korean validation studySang Won Jeon, Changsu Han, Young Hoon Ko, Seo Young Yoon, Chi-Un Pae
Clinical Psychopharmacology and Neuroscience. 2017-02-28 - 38 citationsA Clinically Useful Self-Report Measure of the DSM-5 Anxious Distress Specifier for Major Depressive DisorderMark Zimmerman, Iwona Chelminski, Diane Young, Kristy Dalrymple, Emily Walsh
The Journal of Clinical Psychiatry. 2014-04-29
Journal Articles
- Validity of the DSM‐5 Anxious Distress Specifier for Major Depressive DisorderKristy Dalrymple, Mark Zimmerman, Depression and Anxiety
Other
- Using scales to monitor symptoms and treatment of depression (measurement based care)Zimmerman M
http://www.uptodate.com/contents/using-scales-to-monitor-symptoms-and-treatment-of-depression-measur
UpToDate, Wolters Kluwer Health - 2013-04-09
Press Mentions
Can Relmada’s Fast-Acting Pill for Major Depressive Disorder Compete in a Crowded Market?May 5th, 2022- Telehealth Safe, Effective for a Challenging Psychiatric DisorderNovember 11th, 2021
- Patient Satisfaction High for Psychiatric Telehealth Platforms in Partial Hospital ProgramMarch 25th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
